Peptide, peptidomimetic and small-molecule drug discovery targeting HIV-1 host-cell attachment and entry through gp120, gp41, CCR5 and CXCR4.
about
Molecular targets for flavivirus drug discoveryPeptide-Like Molecules (PLMs): A Journey from Peptide Bond Isosteres to Gramicidin S Mimetics and Mitochondrial Targeting Agents.Trisubstituted (E)-alkene dipeptide isosteres as beta-turn promoters in the gramicidin S cyclodecapeptide scaffold.Structure-based design, synthesis and biological evaluation of new N-carboxyphenylpyrrole derivatives as HIV fusion inhibitors targeting gp41.Rapid probing of biological surfaces with a sparse-matrix peptide libraryCharacterization and inhibition of norovirus proteases of genogroups I and II using a fluorescence resonance energy transfer assay.Development of a high-throughput screening-compatible assay for the discovery of inhibitors of the AF4-AF9 interaction using AlphaScreen technologyA novel bivalent HIV-1 entry inhibitor reveals fundamental differences in CCR5-μ-opioid receptor interactions between human astroglia and microglia.Surface modifications of nanocarriers for effective intracellular delivery of anti-HIV drugs.Prodrug and conjugate drug delivery strategies for improving HIV/AIDS therapy.Interactions of HIV-1 proteins as targets for developing anti-HIV-1 peptides.Synthesis, Biological Evaluation and Molecular Docking Studies of Novel 4-Arylpyridin-1(4H)-yl) benzoic acid Derivatives as Anti-HIV-1 Agents.The effect of N-methylation of amino acids (Ac-X-OMe) on solubility and conformation: a DFT study.Update on the development of HIV entry inhibitors
P2860
Q21999123-A5253263-349C-4330-9848-41EC72C2E112Q28382825-BB5C6687-DD2F-4179-A56F-5135EDC0A0D7Q33259315-A97AA58D-FBAB-446F-8D79-1406F6082A50Q33638192-9A968C7E-7943-48D1-8EAD-01F1C3BFBE87Q33999803-1B3E6068-050A-43BC-9803-46A1F6187C79Q34112325-989F0248-4FC9-41D8-98B5-F97624F821CAQ34726135-7DCF09B4-A6FB-4CEA-8006-25EDB3A27A71Q37570243-99876F3F-E9A7-48C8-9365-91312580EBE0Q37639557-32E20CCC-C5EF-4289-A6A4-FFB973C1FD92Q37780687-0513C4E8-A91F-482D-B295-9BD1783E995EQ38524164-2034CA87-9EBC-4ED2-BB88-DB5ABDAEB5B2Q38694321-F71929C3-72F0-48BC-8EF7-9E844F21B8F3Q40626372-FF4B021E-F85C-457C-A5A8-5E088155C5DFQ58388992-3463CEE9-5250-4BC1-A40E-AF07A72AFF6D
P2860
Peptide, peptidomimetic and small-molecule drug discovery targeting HIV-1 host-cell attachment and entry through gp120, gp41, CCR5 and CXCR4.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Peptide, peptidomimetic and sm ...... h gp120, gp41, CCR5 and CXCR4.
@ast
Peptide, peptidomimetic and sm ...... h gp120, gp41, CCR5 and CXCR4.
@en
type
label
Peptide, peptidomimetic and sm ...... h gp120, gp41, CCR5 and CXCR4.
@ast
Peptide, peptidomimetic and sm ...... h gp120, gp41, CCR5 and CXCR4.
@en
prefLabel
Peptide, peptidomimetic and sm ...... h gp120, gp41, CCR5 and CXCR4.
@ast
Peptide, peptidomimetic and sm ...... h gp120, gp41, CCR5 and CXCR4.
@en
P2093
P2860
P1476
Peptide, peptidomimetic and sm ...... h gp120, gp41, CCR5 and CXCR4.
@en
P2093
Kristjan S Gudmundsson
Terry P Kenakin
Wieslaw M Kazmierski
P2860
P356
10.1111/J.1747-0285.2005.00319.X
P577
2006-01-01T00:00:00Z